Warning letter
JCB Labs LLC: warning letter of Jul 7, 2014
FDA warning letter 410466 · Kansas City District Office
Key facts
| Reference number | 410466 |
|---|---|
| Company | JCB Labs LLC |
| Subject | Compounding Pharmacy/Adulteration/Misbranding |
| Issue date | Jul 7, 2014 |
| Posted date | Jul 7, 2014 |
| Issuing office | Kansas City District Office |
| Product type | Drugs |
| Inspection city | Wichita |
| Inspection ZIP | 67205 |
| Inspection start date | Feb 12, 2013 |
| Letter on fda.gov | web.archive.org |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: